Some time ago Schultz and his colleagues (Schultz et al., 1972; demonstrated that myeloperoxidase, when injected daily into tumour-bearing mice in conjunction with thio-TEPA, causes a significant decrease in the rate of tumour growth. Neither myeloperoxidase nor thio-TEPA alone appeared to be effective, and retardation in tumour growth was only observed as long as treatment was continued.
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In vitro, myeloperoxidase in the presence of hydrogen peroxide and a halide ion exerts a potent cytotoxic activity against a variety of cell types. These include bacteria (Klebanoff & Luebke, 1965; Klebanoff et al., 1966 Klebanoff et al., , 1970  Klebanoff, 1967 Klebanoff, , 1968 McRipley & Sbarra, 1967) , fungi (Lehrer, 1969; Lehrer & Jan, 1970; Diamond et al., 1972; Howard, 1973) , viruses (Belding et al., 1970) , and a variety of mammalian cells (Klebanoff & Smith, 1970; Edelson & Cohn, 1973; Clark et al., 1975; Clark et al., 1976; Clark & Klebanoff, 1977) . Presently available evidence suggests that the toxic activity of myeloperoxidase involves the generation of oxygen radicals or similar highly reactive species (Klebanoff & Clark, 1978) . Other peroxidases such as lactoperoxidase and horseradish peroxidase have similar cytotoxic properties (Oram and Reiter, 1966; Jacques et al., 1975; Reiter, 1978 In order to construct an enzyme system that would function as the peroxidase-H202-halide system in vivo we immobilized the peroxidase together with a hydrogen peroxide producing enzyme onto small solid beads. This would assure that hydrogen peroxide is continually produced in the immediate vicinity of the peroxidase. Since chloride ions are ubiquitiously distributed, no special action was considered necessary to assure the availability of halide ions. Thus, a 20g CNBractivated Sepharose-4 was suspended in 50 ml 0.1 M phosphate buffer, pH 7.0, containing 1% lysine, and the suspension was stirred overnight. The gel was then thoroughly washed with water and stirred for 10h in 5% NaCl. The gel was again washed and then filtered over a Buchner funnel. The packed gel was resuspended in 20 ml buffer and 2ml 50% glutaraldehyde was added. After 1 h stirring at room temp. the gel was washed thoroughly with buffer. The gel was then added to a solution containing 20mg horseradish peroxidase (Sigma, type VI) and 4.5 ml glucose oxidase (A. niger; Sigma, type V, 1000 U ml-1). The mixture was gently shaken overnight at 4°C and the immobilized enzymes were separated from any unbound enzymes by the procedure described by Mosbach and Mattiassen (1976) . The gel was then lyophilized to dryness and the dry powder was stored at -20°until use.
Our first experiments were done using Novikoff hepatoma bearing rats. Three week old SpragueDawley rats were inoculated i.p. with 0.5ml of a Novikoff hepatoma cell suspension and the tumour was allowed to develop for 5 days. Each rat was then injected i.p. with 5mg of the immobilized enzymes, suspended in 1 ml PBS containing 0.1% glucose. This treatment was repeated for 5 consecutive days. All 10 control animals died within 15 days after tumour inoculation. Of the 10 treated animals 9 were still alive 15 days after tumour inoculation and 6 were still alive after 40 days (one animal was sacrificed on the 15th day for a pathological evaluation). A histopathological examination of the contents of the sacrificed rat C) The Macmillan Press Ltd., 1985 indicated the presence of islands of necrotic tumour cells encapsulated by fibroblasts. Necrosis of the tumour appeared to be total and secondary fibroplasia was apparent. The results of similar experiments, using different doses of the immobilized enzymes, are illustrated in Figure 1 and Table I . Administration of a gel containing only glucose oxidase (the peroxidase being omitted in the immobilization procedure) was without any effect. received buffer only. Each group consisted of 6 rats and 24 rats were used as controls. A necropsy of several of the rats treated with the immobilized peroxidases revealed that the toxic action was very specifically directed against the tumour cells; cells from normal tissues immediately adjacent to the necrotic tumour were unaffected and no damage to any normal cells could be detected. This suggested that the peroxidase system may have a low toxicity level for normal tissues.
To verify this point normal, healthy rats were injected i.p. with large amounts of immobilized peroxidase. Groups of 10 rats each were given a single dose of 62.5, 125, 250, 500 and 1000mgkg-1 of the immobilized peroxidase. No toxic effects were observed as a result of these injections and none of the animals died over the test period (21 days). A similar experiment, using amounts up to 600mgkg-' per rat, was done several times with identical results. These data confirm that the toxicity of the peroxidase system in vivo is quite specifically directed toward cancer cells.
We further tested the effectiveness of the immobilized peroxidase system against the B16 mouse melanoma. Injections of 2.5, 5 and 10mg of immobilized peroxidase were given i.p. to groups of 10 mice, starting the day following injection of the tumour cells, and treatment was continued daily for 9 days. The results in terms of survival time were less dramatic than those observed with the Novikoff hepatoma, as illustrated in Figure 2 .
Finally, some experiments were done with DMBA induced rat mammary tumours. Female rats, 50 days old, were given 20 mg DMBA in 1.0 ml sesame oil intragastrically. Mammary tumours developed from 1 to 6 months later. Histology on biopsies of these tumours revealed the development of 9 epithelial papillary adenomas and 6 fibroblastic adenomas. Seven of the animals with epithelial tumours and 5 animals with fibroblastic tumours received daily injections of 5 mg horseradish peroxidase and glucose oxidase, immobilized onto polylysine and suspended in 1 ml PBS, for 6 consecutive days directly into the mammary tumours. The size of the tumours was then monitored for a period of up to 6 months following treatment. One of the epithelial tumours underwent a total regression within 6 weeks, but reappeared at the same site 6 months later. The other epithelial tumours either decreased in size or remained the same. The fibroblastic tumours, however, increased rapidly in size, perhaps even somewhat faster than the control tumour. We conclude that under the conditions of the experiment the peroxidase caused a definite cytostasis and sometimes a regression of the epithelial tumours, but the enzyme is without effect or might even stimulate the growth of the fibroblastic tumours. Since both types of tumours are benign, no information is available concerning metastasis.
The most exciting and surprising observation in this series of experiments was the high specificity of the toxic activity of the peroxidases toward tumour cells and the very low toxicity of the enzymes toward normal tissues. This was unexpected in view of the toxic action of the enzyme system in vitro, which appears to have little or no specificity for any given cell type. The high specificity in vivo of the peroxidase system could be a definite advantage if this system can be developed into a chemotherapeutic agent.
It is further of interest to note the total lack of a relationship between dose and number of surviving animals. The results in Table I clearly indicate that the lowest dose, 1.25mgkg-1, is as effective as any of the higher doses. Yet none of the doses used yielded 100% survival. A possible explanation for these observations is that the tumouricidal activity of the immobilized enzyme system is fully dependent on the presence of one or more endogenous entities, which are present in insufficient amounts to yield 100% survival. The participation of such entities could also help to explain the very high specificity of the peroxidase system for tumour cells in vivo, since no specificity is found in vitro.
It is obviously extremely important to elucidate the basis for the in vivo specificity of the peroxidase system and to identify the endogenous factor(s) that direct the toxic activity of the enzyme specifically toward the tumour cells or that protect normal cells from the toxic activity. Such information could prove to be useful not only in understanding why certain tumours are more responsive to the action of peroxidases than others, but also in our approach to design new and more specific anticancer agents.
